Skip to main content
Premium Trial:

Request an Annual Quote

Coronavirus RNA, Host Protein Interactions Collected in CovInter Database

For a paper appearing in Nucleic Acids Research, a team from Zhejiang University, Fudan University, and other centers presents an "interaction data between coronavirus RNAs and host proteins" (CovInter) database that tallies such viral RNA-host protein interactions, along with the possible consequences of these interactions. After focusing in on almost 10,200 coronavirus RNA-host protein interactions involving more than 300 viral RNAs and nearly 1,300 host proteins found through a systematic literature review, the researchers considered the pathways, functions, and expression patterns associated with the interacting host proteins. While more than 400 host proteins appeared to have anti-viral functions, for example, more than 350 proteins appeared to be pro-viral. "Given the devastating and persistent threat of coronaviruses, CovInter is highly expected to fill the gap in the whole process of the 'molecular arms race' between viruses and their hosts, which will then aid in the discovery of new antiviral therapies," the authors suggest.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.